CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology

CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology

ash

2 months
27 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:

Shouryadeep Srivastava, MBBS, PhD of @TakedaOncology discusses CML patients prescribed ponatinib vs bosutinib: what is next for research?

Up Next Autoplay